Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations

Am J Hum Genet. 2008 Jul;83(1):64-76. doi: 10.1016/j.ajhg.2008.06.015.

Abstract

Autosomal-Recessive Osteopetrosis (ARO) comprises a heterogeneous group of bone diseases for which mutations in five genes are known as causative. Most ARO are classified as osteoclast-rich, but recently a subset of osteoclast-poor ARO has been recognized as due to a defect in TNFSF11 (also called RANKL or TRANCE, coding for the RANKL protein), a master gene driving osteoclast differentiation along the RANKL-RANK axis. RANKL and RANK (coded for by the TNFRSF11A gene) also play a role in the immune system, which raises the possibility that defects in this pathway might cause osteopetrosis with immunodeficiency. From a large series of ARO patients we selected a Turkish consanguineous family with two siblings affected by ARO and hypogammaglobulinemia with no defects in known osteopetrosis genes. Sequencing of genes involved in the RANKL downstream pathway identified a homozygous mutation in the TNFRSF11A gene in both siblings. Their monocytes failed to differentiate in vitro into osteoclasts upon exposure to M-CSF and RANKL, in keeping with an osteoclast-intrinsic defect. Immunological analysis showed that their hypogammaglobulinemia was associated with impairment in immunoglobulin-secreting B cells. Investigation of other patients revealed a defect in both TNFRSF11A alleles in six additional, unrelated families. Our results indicate that TNFRSF11A mutations can cause a clinical condition in which severe ARO is associated with an immunoglobulin-production defect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acid Phosphatase / metabolism
  • Actins / metabolism
  • Agammaglobulinemia / blood*
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Argentina
  • Arginine / metabolism
  • Biopsy
  • Case-Control Studies
  • Cell Line, Transformed
  • Cell Proliferation
  • Cell Transformation, Viral
  • Cells, Cultured
  • Cohort Studies
  • Consanguinity
  • Cysteine / metabolism
  • DNA Mutational Analysis
  • Dendrites / physiology
  • Female
  • Genes, Recessive
  • Herpesvirus 4, Human / physiology
  • Heterozygote
  • Homozygote
  • Humans
  • Ilium / surgery
  • Isoenzymes / metabolism
  • Leukocyte Common Antigens / metabolism
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / pathology
  • Lipopolysaccharides / pharmacology
  • Macrophage Colony-Stimulating Factor / pharmacology
  • Male
  • Models, Immunological
  • Molecular Sequence Data
  • Mutation, Missense
  • Osteoclasts / metabolism
  • Osteoclasts / pathology*
  • Osteoclasts / ultrastructure
  • Osteopetrosis / diagnosis
  • Osteopetrosis / diagnostic imaging
  • Osteopetrosis / genetics*
  • Osteopetrosis / pathology
  • Osteopetrosis / physiopathology
  • Osteoprotegerin / metabolism
  • Pakistan
  • Pedigree
  • Polymorphism, Genetic
  • Protein Structure, Tertiary
  • RANK Ligand / metabolism
  • Radiography, Thoracic / methods
  • Receptor Activator of Nuclear Factor-kappa B / chemistry
  • Receptor Activator of Nuclear Factor-kappa B / genetics*
  • Receptor Activator of Nuclear Factor-kappa B / immunology
  • Receptors, Vitronectin / metabolism
  • Sequence Homology, Amino Acid
  • Tartrate-Resistant Acid Phosphatase
  • Turkey

Substances

  • Actins
  • Isoenzymes
  • Lipopolysaccharides
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Vitronectin
  • TNFRSF11A protein, human
  • Macrophage Colony-Stimulating Factor
  • Arginine
  • Acid Phosphatase
  • Tartrate-Resistant Acid Phosphatase
  • Leukocyte Common Antigens
  • Cysteine